Keywords: flamel, tap, enter, licensing, deal, technologies, says
Flamel and Tap enter licensing deal
Article | 27 September 2004
Flamel Technologies says that USA-based drugmaker Tap Pharmaceuticals has licensed the global rights for its Micropump technology, a controlled-release platform ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
